SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Quak JJ, van Dongen GAMS, Brakkee JG, Scheper RJ, Snow GB, Meijer CJLM. A 22-kd surface antigen detected by monoclonal antibody E48 is exclusively expressed in stratified squamous and transitional epithelia. Am J Pathol 1990; 136: 1917.
  • 2
    Gerretsen M, Visser GW, van Walsum M, Meijer CJLM, Snow GB, van Dongen GAMS. 186Re-labeled monoclonal antibody E48 immunoglobulin-G mediated therapy of human head and neck squamous cell carcinoma xenografts. Cancer Res 1993; 53: 35249.
  • 3
    De Bree R, Roos JC, Quak JJ, den Hollander W, Wilhelm AJ, van Lingen A, Snow GB, van Dongen GAMS. Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab′)2 in patients with head and neck cancer. Clin Cancer Res 1995; 1: 27786.
  • 4
    Brakenhoff RH, Stroomer JGW, ten Brink C, de Bree R, Weima SM, Snow GB, van Dongen GAMS. Sensitive detection of squamous cells in bone marrow and blood of head and neck cancer patients by E48 reverse transcriptase-polymerase chain reaction. Clin Cancer Res 1999; 5: 72532.
  • 5
    Nieuwenhuis EJC, Jaspars LH, Castelijns JA, Bakker B, Wishaupt RGA, Denkers F, Leemans CR, Snow GB, Brakenhoff RH. Quantitative molecular detection of minimal residual head and neck cancer in lymph node aspirates. Clin Cancer Res 2002; (in press).
  • 6
    De Bree R, Roos JC, Quak JJ, Den Hollander W, Snow GB, van Dongen GAMS. Clinical screening of monoclonal antibodies 323/A3, cSF-25 and K928 for suitability of targetting tumours in the upper aerodigestive and respiratory tract. Nucl Med Commun 1994; 15: 61327.
  • 7
    Brakenhoff RH, Gerretsen M, Knippels EMC, van Dijk M, van Essen H, Olde Weghuis D, Sinke RJ, Snow GB, van Dongen GAMS. The human E48 antigen, highly homologous to the murine Ly-6 antigen ThB, is a GPI-anchored molecule apparently involved in keratinocyte cell–cell adhesion. J Cell Biol 1995; 129: 167789.
  • 8
    Flood PM, Dougherty JP, Ron Y. Inhibition of Ly-6A antigen expression prevents T cell activation. J Exp Med 1990; 172: 11520.
  • 9
    Lee SK, Su B, Mahler SE, Bothwell AL. Ly-6A is required for T cell receptor expression and protein tyrosine kinase fyn activity. EMBO J 1994; 13: 216776.
  • 10
    Izon DJ, Oritani K, Hamel M, Calvo CR, Boyd RL, Kincade PW, Kruisbeek AM. Identification and functional analysis of Ly-6A/E as a thymic and bone marrow stromal antigen. J Immunol 1996; 156: 23919.
  • 11
    Bamezai A, Palliser D, Berezovskaya A, McGrew J, Higgins K, Lacey E, Rock RL. Regulated expression of Ly-6A.2 is important for T cell development. J Immunol 1995; 154: 42339.
  • 12
    Schrijvers AHGJ, Gerretsen M, Fritz JM, van Walsum M, Quak JJ, Snow GB, van Dongen GAMS. Evidence for a role of the monoclonal antibody E48 defined antigen in cell–cell adhesion in squamous epithelia and head and neck squamous cell carcinoma. Exp Cell Res 1991; 196: 2649.
  • 13
    Bamezai A, Rock KL. Overexpressed Ly-6A.2 mediates cell–cell adhesion by binding a ligand expressed on lymphoid cells. Proc Natl Acad Sci USA 1995; 92: 42948.
  • 14
    Hanninen A, Jaakkola I, Salmi M, Simell O, Jalkanen S. Ly-6C regulates endothelial adhesion and homing of CD8+ T cells by activating integrin-dependent adhesion pathways. Proc Natl Acad Sci USA 1997; 94: 6898903.
  • 15
    Eshel R, Zanin A, Sagi-Assif O, Meshel T, Smorodinsky NI, Dwir O, Alon R, Brakenhoff R, van Dongen G, Witz IP. The GPI-linked Ly-6 antigen E48 regulates expression levels of the FX enzyme and of E-selectin ligands on head and neck squamous cell carcinoma cells. J Biol Chem 2000; 275: 1283340.
  • 16
    Eshel R, Zanin A, Kapon D, Sagi-Assif O, Brakenhoff R, van Dongen G, Witz IP. Human Ly-6 antigen E48 (Ly-6D) regulates important interaction parameters between endothelial cells and head-and-neck squamous carcinoma cells. Int J Cancer 2002; 98: 80310.
  • 17
    Apostolopoulos J, McKenzie IFC, Sandrin MS. Ly6d-L, a cell surface ligand for mouse Ly6d. Immunity 2000; 12: 22332.
  • 18
    Hogenesch H, de Geus B, Tielen F, Rozing J. Constitutive expression of Ly-6A.2 on murine keratinocytes and inducible expression on TCR gamma delta+ dendritic epidermal T-cells. J Dermatol Sci 1993; 5: 11421.
  • 19
    Welters MJ, Fichtinger-Schepman AM, Baan RA, Hermsen MAJA, van der Vijgh WJF, Cloos J, Braakhuis BJM. Relationship between the parameters cellular differentiation, doubling time and platinum accumulation and cisplatin sensitivity in a panel of head-and-neck cancer cell lines. Int J Cancer 1997; 71: 4105.
  • 20
    Reid CB, Cloos J, Snow GB, Braakhuis BJ. A simple and reliable technique for culturing of human oral keratinocytes and fibroblasts. Acta Otolaryngol 1997; 117: 62833.
  • 21
    Mensink EJBM, van de Locht A, Schattenberg AV, Linders EH, Schaap N, Geurts van Kessel A, de Witte T. Quantitation of minimal residual disease in Philadelphia chromosome positive myeloid leukaemia patients using real-time quantitative RT-PCR Br J Haematol 1998; 102: 76874.
  • 22
    Davies A, Simmonds DL, Hale G, Harrison RA, Tighe H, Lachmann PJ, Waldmann H. CD59, an Ly-6 like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med 1989; 170: 63754.
  • 23
    Mao M, Yu M, Tong JH, Ye J, Zhu J, Huang QH, Fu G, Yu L, Zhao SY, Waxman S, Lanotte M, Wang ZY, et al. RIG-E, a human homolog of the murine Ly-6 family, is induced by retinoic acid during the differentiation of acute promyelocytic leukemia cell. Proc Natl Acad Sci USA 1996; 93: 59104.
  • 24
    Capone MC, Gorman DM, Ching EP, Zlotnik A. Identification through bioinformatics of cDNAs encoding human thymic shared Ag-1/Stem Cell Ag-2. A new member of the human Ly-6 family. J Immunol 1996; 157: 96973.
  • 25
    Furuhata T, Tokino T, Urona T, Nakamura Y. Isolation of a novel GPI-anchored gene specifically regulated by P53; correlation between its expression and anti-cancer drug sensitivity. Oncogene 1996; 13: 196570.
  • 26
    Horie M, Okutomi K, Taniguchi Y, Ohbuchi Y, Suzuki M, Takahashi E. Isolation and characterization of a new member of the human Ly6 gene family (Ly6H). Genomics 1998; 53: 3658.
  • 27
    Reiter RE, Gu Z, Watabe T, Thomas G, Szigeti K, Davis E, Wahl M, Nisitani S, Yamashiro J, Le Beau MM, Loda M. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci USA 1998; 95: 173540.
  • 28
    Ribas G, Neville M, Wixon JL, Cheng J, Campbell RD. Genes encoding three new members of the leukocyte antigen 6 superfamily and a novel member of Ig superfamily, together with genes encoding the regulatory nuclear chloride ion channel protein (hRNCC) and a Nw-Nw-dimethylarginine dimethylaminohydrolase homologue, are found in a 30-kb segment of the MHC class III region. J Immunol 1999; 163: 27887.
  • 29
    Adermann K, Wattler F, Wattler S, Heine G, Meyer M, Forssmann WG, Nehls M. Structural and phylogenic characterization of human SLURP-1, the first secreted mammalian member of the Ly-6/uPAR protein superfamily. Protein Sci 1999; 8: 8109.
  • 30
    Powell MB, Marchbank KJ, Rushmere NK, van den Berg CW, Morgan BP. Molecular cloning, chromosomal localization, expression and functional characterization of the mouse analogue of human CD59. J Immunol 1997; 158: 1692702.
  • 31
    Gumley TP, McKenzie IFC, Kozak C, Sandrin MS. Isolation and characterization of cDNA clones for the mouse thymocyte B cell antigen (ThB). J Immunol 1992; 149: 26158.
  • 32
    MacNeil I, Kennedy J, Godfrey DI, Jenkins NA, Masciantonio M, Mineo C, Gilber DJ, Copeland NG, Boyd RL, Zlotnik A. Isolation of a cDNA encoding thymic shared antigen-1. J Immunol 1993; 151: 691323.
  • 33
    Xue H, O'Neill D, Wang X, Wolgemuth DJ, Bank A. HemT-3, an alternative transcript of mouse gene HemT specific to male germ cells. Gene 1999; 240: 1939.
  • 34
    Apostolopoulos JA, Chrisholm LJ, Sandrin MS. Identification of mouse Ly6H and its expression in normal tissue. Immunogenetics 1999; 49: 98790.
  • 35
    Ross S, Spencer SD, Lasky LA, Koeppen H. Selective expression of murine prostate stem cell antigen in fetal and adult tissues and the transgenic adenocarcinoma of the mouse prostate model of prostate carcinogenesis. Am J Pathol 2001; 158: 80916.
  • 36
    LeClair KP, Palfree RGE, Flood PM, Hammerling U, Bothwell A. Isolation of a murine Ly-6 cDNA reveals a new multigene family. EMBO J 1986; 5: 322734.
  • 37
    Reiser H, Coligan J, Palmer E, Benacerraf B, Rock KL. Cloning and expression of a cDNA for the T-cell activating protein TAP. Proc Natl Acad Sci USA 1988; 85: 22559.
  • 38
    Palfree RG, Sirlin S, Dumont FJ, Hammerling U. N-terminal and cDNA characterization of murine lymphocyte antigen Ly-6C.2. J Immunol 1988; 140: 30510.
  • 39
    Fleming TJ, O'Huigin C, Malek TR. Characterization of two novel Ly-6 genes. J Immunol 1993; 150: 537990.
  • 40
    Pflugh DL, Maher SE, Bothwell ALM. Ly-6I, a new member of the murine Ly-6 superfamily with a distinct expression pattern. J Immunol 2000; 165: 31321.
  • 41
    Patterson JMM, Johnson MH, Zimonjic DB, Graubert TA. Characterization of Ly-6M, a novel member of the Ly-6 family of hematopoietic proteins. Blood 2000; 95: 312532.
  • 42
    Gumley TP, McKenzie IFC, Kozak C, Sandrin MS. Tissue expression, structure and function of the murine Ly-6 family of molecules. Immunol Cell Biol 1995; 73: 27796.
  • 43
    Brakenhoff RH, van Dijk M, Rood-Knippels EMC, Snow GB. A gain of novel tissue specificity in the human Ly-6 gene E48. J Immunol 1997; 159: 487986.
  • 44
    Bahrenberg G, Brauers A, Joost HG, Jakse G. Reduced expression of PSCA, a member of the Ly-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors. Biochem Biophys Res Commun 2000; 275: 7838.
  • 45
    Bahrenberg G, Brauers A, Joost HG, Jakse G. PSCA expression is regulated by phorbol ester and cell adhesion in the bladder carcinoma cell line RT112. Cancer Lett 2001; 168: 3743.
  • 46
    Fischer J, Bouadjar B, Heilig R, Huber M, Lefevre C, Jobard F, Macari F, Bakija-Konsuo A, Ait-Belkacem F, Weissenbach J, Lathrop M, Hohl D, et al. Mutations in the gene encoding SLURP-1 in mal de Meleda. Hum Mol Genet 2001; 10: 87580.
  • 47
    Katz BZ, Eshel R, Sagi-Assif O, Witz, IP. An association between high Ly-6A/E expression on tumor cells and a high malignant phenotype. Int J Cancer 1994; 59: 68491.
  • 48
    Gu Z, Thomas G, Yamashiro J, Shintaku IP, Dorey F, Raitano A, Witte ON, Said JW, Loda M, Reiter RE. Prostate stem cell antigen (PSCA) expression increases with high Gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene 2000; 19: 128896.
  • 49
    Argani P, Rosty C, Reiter RE, Wilentz RE, Murugesan SR, Leach SD, Ryu B, Skinner HG, Goggins M, Jaffee EM, Yeo CJ, Cameron JL, et al. Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res 2001; 6: 43204.
  • 50
    Bergamo NA, Rogatto SR, Poli-Frederico RC, Reis PP, Kowalski LP, Zielenska M, Squire JA. Comparative genomic hybridization analysis detects frequent over-representation of DNA sequences at 3q, 7q, and 8q in head and neck carcinomas. Cancer Genet Cytogenet 2000; 119: 4855.
  • 51
    Jin C, Jin Y, Wennerberg J, Åkervall J, Dictor M, Mertens F. Karyotypic heterogeneity and clonal evolution in squamous cell carcinomas of the head and neck. Cancer Genet Cytogenet 2002; 132: 8596.
  • 52
    Reiter RE, Sato I, Thomas G, Qian J, Gu Z, Watabe T, Loda M, Jenkins RB. Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer. Genes Chromosomes Cancer 2000; 27: 95103.